doi:10.14309/ajg.0000000000001036 Chassard C, Dapoigny M, Scott KP, et al
Not all patients benefit equally from GLP-1 therapy, and individual factorsincluding baseline metabolic function, comorbidities, and genetic backgroundshape treatment selection
A 2.5 mg dose equals just 0.25 mL (25 units)
Its essential to consult a healthcare professional before starting any new supplement
A comprehensive approach addresses hydration, nutrition, medication management, and monitoring
Although Retatrutide itself is still investigational, the broader trend of targeted peptide interactions with multiple hormone receptors is of particular interest to those exploring Peptide Therapy approaches for metabolic health